logo-loader
RNS
viewHikma Pharmaceuticals PLC

Hikma Pharmaceutical - Director/PDMR Shareholding

RNS Number : 9314J
Hikma Pharmaceuticals Plc
16 April 2020
 

 

Hikma Pharmaceuticals PLC

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Said Darwazah

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Said Darwazah

2

Reason for the notification

a)

Position/status

Executive Chairman

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each (Shares)

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Conditional Shares acquired from the grant made on 13 April 2017 and vested on 14 April 2020 under the 2014 EIP Element C.

c)

Price(s) and volume(s)

Price(s): £nil

Volume(s): 36,438

d)

Aggregated information

N/A

e)

Date of the transaction

15 April 2020

f)

Place of the transaction

London Stock Exchange (XLON)

Mazen Darwazah

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mazen Darwazah

2

Reason for the notification

a)

Position/status

Executive Vice Chairman

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each (Shares)

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Conditional Shares acquired from the grant made on 13 April 2017 and vested on 14 April 2020 under the 2014 EIP Element C.

c)

Price(s) and volume(s)

Price(s): £nil

Volume(s): 19,318

d)

Aggregated information

N/A

e)

Date of the transaction

15 April 2020

f)

Place of the transaction

London Stock Exchange (XLON)

 

Majda Labadi

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Majda Labadi

2

Reason for the notification

a)

Position/status

PDMR

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each (Shares)

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Conditional Shares acquired from the grant made on 13 April 2017 and vested on 14 April 2020 under the 2014 EIP Element C.

c)

Price(s) and volume(s)

Price(s): £nil

Volume(s): 16,146

d)

Aggregated information

N/A

e)

Date of the transaction

15 April 2020

f)

Place of the transaction

London Stock Exchange (XLON)

 

Riad Mishlawi

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Riad Mishlawi

2

Reason for the notification

a)

Position/status

PDMR

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each (Shares)

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Conditional Shares acquired from the grant made on 13 April 2017 and vested on 14 April 2020 under the 2014 EIP Element C.

c)

Price(s) and volume(s)

Price(s): £nil

Volume(s): 20,146

d)

Aggregated information

N/A

e)

Date of the transaction

15 April 2020

f)

Place of the transaction

London Stock Exchange (XLON)

Bassam Kanaan

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Bassam Kanaan

2

Reason for the notification

a)

Position/status

PDMR

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each (Shares)

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Conditional Shares acquired from the grant made on 13 April 2017 and vested on 14 April 2020 under the 2014 EIP Element C.

c)

Price(s) and volume(s)

Price(s): £22.82

Volume(s): 23,233

d)

Aggregated information

Number of Shares: 23,233

Price: £530,177

e)

Date of the transaction

14 April 2020

f)

Place of the transaction

London Stock Exchange (XLON)

Khalid Nabilsi

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Khalid Nabilsi

2

Reason for the notification

a)

Position/status

PDMR

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each (Shares)

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Conditional Shares acquired from the grant made on 13 April 2017 and vested on 14 April 2020 under the 2014 EIP Element C.

c)

Price(s) and volume(s)

Price(s): £22.82

Volume(s): 23,751

d)

Aggregated information

Number of Shares: 23,751

Price: £541,998

e)

Date of the transaction

14 April 2020

f)

Place of the transaction

London Stock Exchange (XLON)

 

Susan Ringdal

a)

Name

Susan Ringdal

2

Reason for the notification

a)

Position/status

PDMR

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each (Shares)

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Shares acquired from the exercise of nil-cost options granted on 17 May 2013 and 11 June 2014 under the 2007 LTIP and nil-cost options granted on 10 April 2015 under the 2014 EIP Elements B and C

c)

Price(s) and volume(s)

Share Plan

Price

Volume

2013 LTIP

£22.82

18,424

2014 LTIP

£22.82

11,774

2015 EIP B

£22.82

6,006

2015 EIP C

£22.82

6,006

 

d)

Aggregated information

Number of Shares: 42,210

Price: £963,232

e)

Date of the transaction

15 April 2020

f)

Place of the transaction

London Stock Exchange (XLON)

 

Brian Hoffmann

a)

Name

Brian Hoffmann

2

Reason for the notification

a)

Position/status

PDMR

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each (Shares)

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Shares acquired from the vesting of nil-cost options granted on 11 May 2016 and 13 April 2017 under the 2014 EIP Element B.

c)

Price(s) and volume(s)

Share Plan

Price

Volume

2016 EIP B

£22.34

8,230

2017 EIP B

£22.34

9,327

 

d)

Aggregated information

Number of Shares: 17,557

Price: £392,223

e)

Date of the transaction

16 April 2020

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

a)

Name

Brian Hoffmann

2

Reason for the notification

a)

Position/status

PDMR

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each (Shares)

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Disposal of Shares.

c)

Price(s) and volume(s)

Price(s): £22.79

Volume(s): 2,219

d)

Aggregated information

Number of Shares: 2,219

Price: £50,571

e)

Date of the transaction

14 April 2020

f)

Place of the transaction

London Stock Exchange (XLON)

 

Peter Speirs
Company Secretary, responsible for releasing this announcement
16 April 2020
+44 (0) 20 7399 2760

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHBSGDSUGBDGGL

Quick facts: Hikma Pharmaceuticals PLC

Price: 2105

Market: AIM
Market Cap: £4.85 billion
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE